Log In
BCIQ
Print this Print this
 

MIV-802

  Manage Alerts
Collapse Summary General Information
Company Medivir AB
DescriptionUridine nucleotide HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionPolymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV infection
Regulatory Designation
PartnerTrek Therapeutics PBC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/31/2016

Undisclosed

Undisclosed

Undisclosed

08/17/2016

Undisclosed

0

Undisclosed

Get a free BioCentury trial today